4Yamamoto M,Yoshinaga K,Matsuyama A,et al.Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer[J].Oncology,2012,83:10-15.
5Petersen H,Nielsen MJ,Hoilund-Carlsen M,et al.PET/ CT may change diagnosis and treatment in cancer patients[J].Danish Medical Bulletin,2010,10:161-174.
6Engel H, Steinert H, Buck A, et al. Whole-body PET.. phys- iological and artifactual fluorodeoxyglucose accumulations [J]. J NuclMed,1996, 37(3) :441-446.
7Lee JC, Harmett GF, Hughes BG, et a l. The segmental dis- tribution and clinical significance of colorectal fluorodeoxyglu- cose uptake incidentally detected on PET-CT [J]. Nucl Med Commun, 2009, 30(5): 333-337.
8Philip S. Incidental focal hypermetabolic colorectal lesions i dentified by positron emission tomography: prevalence of ma- lignancy [J]. Abdom maging, 2011, 36(2): 165-169.
9Ryogo M, Takashi T, Seishi J, et al. Observer variation study of the assessment and diagnosis of incidental colonic FDG uptake [J]. Annals of Nuclear Medicine, 2013, 27(5) : 468-477.
10Cohade C, Osman M, Leal J, et al. Direct comparison of (18) F-FDG PET and PET/CT in patients with colorectal carcino- ma[J]. J Nucl Med, 2003, 44(11): 1797-1803.
